© The Board of Management and Trustees of the British Journal of Anaesthesia 2009. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Red cell transfusion in elective cardiac surgery patients: where do we go from here?
| The first 10% of the full text of this article appears below. |
Transfusion of red blood cells (RBCs) is one of the most common interventions carried out upon the cardiac surgery population in the postoperative period. Of late, this practice has received increasing attention in terms of the appropriateness of the decision to transfuse, the deleterious consequences of unnecessary transfusion, and the possibility for viable alternatives.1 We wish to highlight recent developments in these areas and suggest where the future may lie in terms of an evidence-based transfusion practice in cardiac surgery.
Appropriate use of RBCs
Since 1942, any decision to administer RBCs has largely been based upon a haemoglobin concentration [Hb] threshold with little consideration for any other patient variables.2 Largely prompted by the availability of high-quality data
Deleterious consequences of RBC transfusion
Transfusion alternatives
Department of Cardiothoracic Surgery and the Scottish National Blood Transfusion Service
The Royal Infirmary of Edinburgh
Little France Crescent
Old Dalkeith Road
Edinburgh EH16 5SA
UK
* E-mail: rdslight@mac.com
Read all E-letters![]()
CiteULike
Connotea
Del.icio.us What's this?
E-letters: